| Nine Phase One (mannote sodium) / Shanghai Greenvalley |
ChiCTR2100042680: Preliminary study on the efficacy of Sodium Oligomannate capsule in the treatment of early and Middle stage of Parkinson's Disease |
|
|
| Recruiting | 4 | 150 | | Sodium Oligomannate capsule ;placebo | Shanghai Tongji Hospital; Shanghai Tongji Hospital, Shanghai Green Valley Pharmaceutical | Parkinson‘s Disease | | | | |
ChiCTR2300073760: An open study to evaluate the efficacy and safety of mannote sodium (GV-971) in the treatment of mild to moderate Alzheimer's disease with depressive and anxiety symptoms |
|
|
| Recruiting | 4 | 72 | | All subjects received oral gv-971 at 900 mg/day | Beijing Anding Hospital Affiliated to Capital Medical University; Beijing Anding Hospital Affiliated to Capital Medical University, Beijing Anding Hospital Affiliated to Capital Medical University | Alzheimer's disease | | | | |
NCT05058040: A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971) |
|
|
| Active, not recruiting | 4 | 2500 | RoW | Sodium Oligomannate Capsules | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | Alzheimer Disease | 01/25 | 04/25 | | |
| Active, not recruiting | 4 | 800 | RoW | Sodium Oligomannate Capsules (GV-971) | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | Alzheimer Disease | 01/25 | 06/25 | | |
NCT05430867: Efficacy and Safety of Memantine and Sodium Oligomannate in Patients With Moderate to Severe Alzheimer's Disease |
|
|
| Not yet recruiting | 4 | 150 | NA | Memantine Oral Tablet, Memantine, GV-971 capsule, GV-971 | First Affiliated Hospital Xi'an Jiaotong University | Treatment, Efficacy, Safety, Alzheimer Disease | 07/24 | 12/24 | | |
| Not yet recruiting | 4 | 120 | | GV-971 ;Vehicle ;GV-971+Donepezil ;Vehicle+Donepezil | The First Affiliated Hospital of University of Science and Technology of China; The First Affiliated Hospital of University of Science and Technology of China, 421 Newton Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, China | Alzheimer‘s Disease | | | | |
ChiCTR2100053156: The effect of mobile Internet-based lifestyle assessment and education (Golden Living of AD, GLAD) combined with Mannat sodium capsules in the treatment of patients with mild to moderate cognitive impairment: a multicenter, randomized, parallel controlled clinical study |
|
|
| Recruiting | 4 | 400 | | sodium oligomannate capsules combined with GLAD model ;sodium oligomannate capsules and routine disease education | Shanghai Tenth People's Hospital; Shanghai Tenth People's Hospital, Shanghai Green Valley Pharmaceutical Co., Ltd. | Alzheimer's disease | | | | |
NCT05908695: An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease |
|
|
| Recruiting | 4 | 1312 | RoW | GV-971, Placebo | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | Alzheimer's Disease | 06/29 | 12/29 | | |
ChiCTR2000039219: A multicentre observational study of the efficacy and safety of Sodium Oligomannate Capsules in the treatment of Alzheimer's disease |
|
|
| Recruiting | 4 | 100 | | No intervention | The First Affiliated Hospital of Chongqing Medical University; The First Affiliated Hospital of Chongqing Medical University, self-raised | Alzheimer disease | | | | |
2020-001755-41: Phase 3 clinical trial studying sodium oligomannate (GV-971) for treatment of patients with mild to moderate Alzheimer’s disease |
|
|
| Not yet recruiting | 3 | 2046 | RoW, Europe | Sodium Oligomannate, GV-971, Capsule | Green Valley (Shanghai) Pharmaceuticals Co., Ltd., Green Valley (Shanghai) Pharmaceuticals Co., Ltd., Green Valley (Shanghai) Pharmaceuticals Co., Ltd | mild to moderate Alzheimer’s disease, mild to moderate Alzheimer’s disease, Diseases [C] - Nervous System Diseases [C10] | | | | |
ChiCTR2100053873: Effects of GV-971 on serum NFL levels in Parkinson's disease patients with cognitive impairment - a cohort study |
|
|
| Not yet recruiting | N/A | 84 | | Other anti-dementia drugs ;GV971 | Zhujiang Hospital of Southern Medical University; Zhujiang Hospital of Southern Medical University, self-financed | Parkinson's disease with cognitive impairment | | | | |
NCT05545605: Efficacy and Safety of Sodium Oligomannate in the Prevention of PSCI |
|
|
| Not yet recruiting | N/A | 116 | RoW | Sodium oligomannate, Placebo capsule | Nanfang Hospital of Southern Medical University | Ischemic Stroke | 12/23 | 12/23 | | |
ChiCTR2300078993: Valuation of the effectiveness and safety of Sodium Oligomannate (GV-971) in the intervention study for overweight/obese individuals |
|
|
| Recruiting | N/A | 30 | | Take three capsules of GV-971 in the morning and three capsules in the evening each day, with an intervention duration of three months.; Take three placebo capsules with the same appearance as GV-971 in the morning and evening each day, with an intervention duration of three months. | Affiliated Brain Hospital of Guangzhou Medical University; Affiliated Brain Hospital of Guangzhou Medical University, self-funded | Obesity | | | | |
FOCI, ChiCTR2200062493: A real-world study of factors related to disease outcome in patients with various types of subjective cognitive impairment, mild cognitive impairment, and dementia |
|
|
| Not yet recruiting | N/A | 500 | | Donepezil ;Memantine ;Sodium oligomannate ;Other medicine | The First Affiliated Hospital of Kunming Medical University; The First Affiliated Hospital of Kunming Medical University, Science and Technology Innovation Team Construction Project of Kunming Medical University (Project No. CXTD202104) | Subjective cognitive impairment, mild cognitive impairment, and dementia | | | | |
NCT05114499: Efficacy and Safety of Donepezil and Sodium Oligomannate in Patients With Mild to Moderate Alzheimer's Disease |
|
|
| Not yet recruiting | N/A | 150 | NA | Donepezil, GV-971 | First Affiliated Hospital Xi'an Jiaotong University | Alzheimer Disease | 12/23 | 12/24 | | |
| NPT-289 / Proclara Biosci |
| No trials found |
| NB-02 / NeuroBo |
| No trials found |
| CV-06 / Cellivery, Ildong |
| No trials found |
| Duvax / Nuravax |
| No trials found |
| HT-ALZ / Hoth Therap |
| No trials found |
| TGR-63 / IGC Pharma |
| No trials found |
